rdf:type |
|
lifeskim:mentions |
umls-concept:C0015260,
umls-concept:C0016017,
umls-concept:C0027051,
umls-concept:C0072348,
umls-concept:C0205225,
umls-concept:C0220901,
umls-concept:C0332293,
umls-concept:C1418370,
umls-concept:C1514496,
umls-concept:C1522609,
umls-concept:C1554112,
umls-concept:C1705930,
umls-concept:C2347515
|
pubmed:issue |
2
|
pubmed:dateCreated |
2004-12-24
|
pubmed:abstractText |
To evaluate the prognostic importance of pre-discharge maximal symptom-limited exercise testing (ET) following acute myocardial infarction (AMI) in the era of aggressive reperfusion.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0195-668X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
119-27
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:15618067-Adult,
pubmed-meshheading:15618067-Aged,
pubmed-meshheading:15618067-Aged, 80 and over,
pubmed-meshheading:15618067-Angioplasty, Balloon, Coronary,
pubmed-meshheading:15618067-Exercise Test,
pubmed-meshheading:15618067-Female,
pubmed-meshheading:15618067-Fibrinolytic Agents,
pubmed-meshheading:15618067-Humans,
pubmed-meshheading:15618067-Male,
pubmed-meshheading:15618067-Middle Aged,
pubmed-meshheading:15618067-Multivariate Analysis,
pubmed-meshheading:15618067-Myocardial Infarction,
pubmed-meshheading:15618067-Patient Discharge,
pubmed-meshheading:15618067-Prognosis,
pubmed-meshheading:15618067-Risk Factors
|
pubmed:year |
2005
|
pubmed:articleTitle |
The prognostic value of pre-discharge exercise testing after myocardial infarction treated with either primary PCI or fibrinolysis: a DANAMI-2 sub-study.
|
pubmed:affiliation |
Department of Cardiology B, The Heart Center, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark. nvaleur@dadlet.dk
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|